UPDATE: MLV & Co Reiterates On Galena Biopharma As External Risks Have Subsided
November 20, 2014 at 10:05 AM EST
In a report published Thursday, MLV & Co analyst Vernon T. Bernardino reiterated a Buy rating on Galena Biopharma (NASDAQ: GALE), and ...